Angiogenesis selectively requires the p110α isoform of PI3K to control endothelial cell migration

被引:427
作者
Graupera, Mariona [2 ]
Guillermet-Guibert, Julie [2 ]
Foukas, Lazaros C. [2 ]
Phng, Li-Kun [1 ]
Cain, Robert J. [3 ]
Salpekar, Ashreena [2 ]
Pearce, Wayne [2 ]
Meek, Stephen [4 ]
Millan, Jaime [3 ]
Cutillas, Pedro R. [2 ]
Smith, Andrew J. H. [4 ]
Ridley, Anne J. [3 ]
Ruhrberg, Christiana [5 ]
Gerhardt, Holger [1 ]
Vanhaesebroeck, Bart [2 ]
机构
[1] Canc Res UK London Res Inst, Vasc Biol Lab, London WC2A 3PX, England
[2] Queen Mary Univ London, Ctr Cell Signalling, Inst Canc, London EC1M 6BQ, England
[3] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England
[4] Univ Edinburgh, Gene Targeting Lab, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland
[5] UCL, Dept Cell Biol, Inst Ophthalmol, London EC1V 9EL, England
基金
英国医学研究理事会; 英国生物技术与生命科学研究理事会;
关键词
D O I
10.1038/nature06892
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Phosphoinositide 3- kinases ( PI3Ks) signal downstream of multiple cell- surface receptor types. Class IA PI3K isoforms(1) couple to tyrosine kinases and consist of a p110 catalytic subunit ( p110 alpha, p110 beta or p110 delta), constitutively bound to one of five distinct p85 regulatory subunits. PI3Ks have been implicated in angiogenesis(2-5), but little is known about potential selectivity among the PI3K isoforms and their mechanism of action in endothelial cells during angiogenesis in vivo. Here we show that only p110 alpha activity is essential for vascular development. Ubiquitous or endothelial cell- specific inactivation of p110 alpha led to embryonic lethality at mid- gestation because of severe defects in angiogenic sprouting and vascular remodelling. p110 alpha exerts this critical endothelial cell- autonomous function by regulating endothelial cell migration through the small GTPase RhoA. p110 alpha activity is particularly high in endothelial cells and preferentially induced by tyrosine kinase ligands ( such as vascular endothelial growth factor ( VEGF)- A). In contrast, p110 delta in endothelial cells signals downstream of G- protein- coupled receptor ( GPCR) ligands such as SDF-1 alpha, whereas p110 delta is expressed at low level and contributes only minimally to PI3K activity in endothelial cells. These results provide the first in vivo evidence for p110- isoform
引用
收藏
页码:662 / 666
页数:5
相关论文
共 31 条
[1]   RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development [J].
Adini, I ;
Rabinovitz, I ;
Sun, JF ;
Prendergast, GC ;
Benjamin, LE .
GENES & DEVELOPMENT, 2003, 17 (21) :2721-2732
[2]   Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110α subunit of phosphoinositide 3-kinase [J].
Bi, L ;
Okabe, I ;
Bernard, DJ ;
Wynshaw-Boris, A ;
Nussbaum, RL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (16) :10963-10968
[3]   Early embryonic lethality in mice deficient in the p110β catalytic subunit of PI 3-kinase [J].
Bi, L ;
Okabe, I ;
Bernard, DJ ;
Nussbaum, RL .
MAMMALIAN GENOME, 2002, 13 (03) :169-172
[4]   Key role of the p110δ isoforrn of PI3K in B-cell antigen and IL-4 receptor signaling:: comparative analysis of genetic and pharmacologic interference with p110δ function in B cells [J].
Bilancio, A ;
Okkenhaug, K ;
Camps, M ;
Emery, JL ;
Ruckle, T ;
Rommel, C ;
Vanhaesebroeck, B .
BLOOD, 2006, 107 (02) :642-650
[5]   p110 delta, a novel phosphatidylinositol 3-kinase catalytic subunit that associates with p85 and is expressed predominantly in leukocytes [J].
Chantry, D ;
Vojtek, A ;
Kashishian, A ;
Holtzman, DA ;
Wood, C ;
Gray, PW ;
Cooper, JA ;
Hoekstra, MF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (31) :19236-19241
[6]   Ultrasensitive and absolute quantification of the phosphoinositide 3-kinase/Akt signal transduction pathway by mass spectrometry [J].
Cutillas, Pedro R. ;
Khwaja, Asim ;
Graupera, Mariona ;
Pearce, Wayne ;
Gharbi, Severine ;
Waterfield, Mike ;
Vanhaesebroeck, Bart .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (24) :8959-8964
[7]   Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation [J].
Dayanir, V ;
Meyer, RD ;
Lashkari, K ;
Rahimi, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) :17686-17692
[8]   Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation [J].
Foukas, LC ;
Claret, M ;
Pearce, W ;
Okkenhaug, K ;
Meek, S ;
Peskett, E ;
Sancho, S ;
Smith, AJH ;
Withers, DJ ;
Vanhaesebroeck, B .
NATURE, 2006, 441 (7091) :366-370
[9]   A specific antagonist of the p110δ catalytic component of phosphatidylinositol 3′-kinase, IC486068, enhances radiation-induced tumor vascular destruction [J].
Geng, L ;
Tan, JH ;
Himmelfarb, E ;
Schueneman, A ;
Niermann, K ;
Fu, A ;
Cuneo, K ;
Kesicki, EA ;
Treiberg, J ;
Hayflick, JS ;
Hallahan, DE .
CANCER RESEARCH, 2004, 64 (14) :4893-4899
[10]   Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells [J].
Gerber, HP ;
Dixit, V ;
Ferrara, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (21) :13313-13316